Is nasal closure an effective treatment for severe refractory epistaxis in HHT? A scoping review and narrative synthesis
Rhinology Journal · 2025
DOI: 10.4193/rhin24.448 ↗Kurz gefasst
Scoping Review in der Zeitschrift Rhinology Journal, 2025. Verfasst von R Bickerton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ear, Nose and Throat Surgery, Imperial College Healthcare Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Epistaxis, Telangiectasia, Hereditary Hemorrhagic, Nasal Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Hereditary haemorrhagic telangiectasia (HHT) is an uncommon genetic disorder characterised by recurrent, severe epistaxis which poses significant management challenges. Nasal closure has emerged as a treatment for refractory cases, however there is limited research on its outcomes. We aim to consolidate existing evidence to assess its efficacy and safety.
Methods
We conducted a systematic search of the Cochrane library, EMBASE, PubMed and non-indexed publications from the past 30 years. Two independent reviewers extracted data and assessed bias from included studies. Findings were summarised via narrative synthesis due to heterogeneity of included studies.
Results
192 patients from ten studies underwent nasal closure. Frequently used outcome measures were validated epistaxis severity scores, Glasgow Benefit Inventory and haemoglobin trends. Surgery improved quality of life and reduced epistaxis severity post-operatively. Partial dehiscence is a frequently reported complication which is usually successfully treated with revision surgery.
Conclusions
Nasal closure reduces epistaxis severity, improving quality of life in patients with severe, refractory HHT-related epistaxis, providing a valuable treatment option for the most challenging cases. The strength of our conclusions is limited by the heterogeneity of outcome measures. To our knowledge, this is the largest pooled database of patients who have undergone nasal closure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ear, Nose and Throat Surgery, Imperial College Healthcare Trust, London, United Kingdom.
- Department of Ear, Nose and Throat Surgery, Imperial College Healthcare Trust, London, United Kingdom; EvidENT Team, University College London, London, United Kingdom.
Zitieren
APA
Bickerton, R., Gera, R., Ross, T., & Rennie, C. (2025). Is nasal closure an effective treatment for severe refractory epistaxis in HHT? A scoping review and narrative synthesis. Rhinology Journal. https://doi.org/10.4193/rhin24.448
Vancouver
Bickerton R, Gera R, Ross T, Rennie C. Is nasal closure an effective treatment for severe refractory epistaxis in HHT? A scoping review and narrative synthesis. Rhinology Journal. 2025. doi:10.4193/rhin24.448
BibTeX
@article{Bickerton2025,
author = {Bickerton, R and Gera, R and Ross, T and Rennie, C},
title = {Is nasal closure an effective treatment for severe refractory epistaxis in HHT? A scoping review and narrative synthesis},
journal = {Rhinology Journal},
year = {2025},
doi = {10.4193/rhin24.448}
}
EUVIMED